CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer.
about
Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in CancerSingle and Multiple Gene Manipulations in Mouse Models of Human CancerEpiregulin is required for lung tumor promotion in a murine two-stage carcinogenesis model.High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma familiesLncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.Identification of candidate target genes of genomic aberrations in esophageal squamous cell carcinoma.Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancerCDKN2A methylation in esophageal cancer: a meta-analysisGenome-wide copy number variation pattern analysis and a classification signature for non-small cell lung cancer.An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer.Novel findings about management of gastric cancer: a summary from 10th IGCC.The DNA Methyltransferase 3B -149 Genetic Polymorphism Modulates Lung Cancer Risk from SmokingNon-invasive quantification of cell-free DNA mutations in plasma during lung tumor progression in mice.Gastric-type endocervical glandular neoplasms associated with aberrant p16 expression and K-RAS gene mutation in Peutz-Jeghers syndrome.Role of p16 deletion and BAP1 loss in the diagnosis of malignant mesothelioma
P2860
Q26739706-5B921DA5-6244-49E6-9FBB-42742D0A542CQ26783920-B569A805-33C4-4548-8C96-BDCA2B5426AEQ27853346-AFD2E26A-AA70-4662-B98E-923D5D36B77FQ28242124-9903906F-459A-438D-845C-A36357A1EFBCQ33648454-EEBC1260-AE75-4C5A-8F43-4B199DDC6D6BQ35492010-F7616CCD-20EA-49AD-A339-97DC608BDB69Q37288218-8DB93ADA-E615-4563-9908-68F7C2565D6DQ37301868-9A33AD72-1091-436C-A793-A5CC3A7703A3Q37588366-D08E739F-ACCF-401D-B69C-CC2DE3910030Q38715453-13C577AD-C100-4F18-A456-0CFF9A2A5DB1Q40256906-6A3523F4-D5F9-44E7-AB15-A5C11AD41ACFQ41637380-35C72603-2709-47F9-9B70-A03C46F34F8CQ42751821-BC6330CF-0B3A-4649-95C9-0232B2C0F3EAQ47714712-0C7CD307-75BD-45F0-92A5-D4781827DF12Q50280090-584BCC1E-2221-4303-B0F4-D9533D3C0EF8Q54342277-CD75A977-FDE0-4DD0-B68C-C351516883A6Q58771136-DABF4984-5CA4-4C63-BF78-209C7571CA99
P2860
CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
CDKN2A/p16 inactivation mechan ...... in non-small-cell lung cancer.
@en
CDKN2A/p16 inactivation mechan ...... in non-small-cell lung cancer.
@nl
type
label
CDKN2A/p16 inactivation mechan ...... in non-small-cell lung cancer.
@en
CDKN2A/p16 inactivation mechan ...... in non-small-cell lung cancer.
@nl
prefLabel
CDKN2A/p16 inactivation mechan ...... in non-small-cell lung cancer.
@en
CDKN2A/p16 inactivation mechan ...... in non-small-cell lung cancer.
@nl
P2093
P2860
P50
P1476
CDKN2A/p16 inactivation mechan ...... in non-small-cell lung cancer
@en
P2093
Adi Gazdar
Chenchen Yang
David Shames
Ite A Laird-Offringa
Jonathan J Rios
Junichi Soh
Kelsie Thu
Michael Q Zhang
P2860
P304
P356
10.1097/JTO.0B013E3182A46C0C
P577
2013-11-01T00:00:00Z